Qube Research & Technologies (QRT)
NAGE

Qube Research & Technologies (QRT)’s Niagen Bioscience NAGE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.18M Sell
1,625,016
-89,623
-5% -$364K ﹤0.01% 1610
2026
Q1 		$7.56M Buy
1,714,639
+652,804
+61% +$3.52M 0.01% 1451
2025
Q4 		$6.75M Buy
1,061,835
+185,605
+21% +$1.29M 0.01% 1590
2025
Q3 		$8.18M Buy
876,230
+203,314
+30% +$2.05M 0.01% 1444
2025
Q2 		$9.7M Sell
672,916
-36,658
-5% -$362K 0.01% 1312
2025
Q1 		$4.9M Buy
709,574
+362,656
+105% +$2.28M 0.01% 1550
2024
Q4 		$1.84M Buy
+346,918
New +$1.9M ﹤0.01% 1908
2024
Q2 		– Sell
-121,339
Closed -$422K – 4889
2024
Q1 		$422K Sell
121,339
-10,455
-8% -$19.3K ﹤0.01% 2631
2023
Q4 		$188K Buy
131,794
+119,184
+945% +$166K ﹤0.01% 2810
2023
Q3 		$18.4K Buy
+12,610
New +$19.7K ﹤0.01% 3169
2022
Q4 		– Sell
-39,570
Closed -$49K – 3089
2022
Q3 		$49K Sell
39,570
-5,201
-12% -$8.37K ﹤0.01% 2141
2022
Q2 		$75K Buy
+44,771
New +$87.6K ﹤0.01% 2036

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NAGE Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Niagen Bioscience (NAGE) stake by 5.2% in Q2 2026, selling an estimated $364K and leaving 1,625,016 shares worth $5.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

Qube Research & Technologies (QRT) first reported a position in NAGE in Q2 2022 and has held it in 12 quarters since. The position peaked at $9.7M in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,625,016 shares of Niagen Bioscience worth $5.18M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 89,623 Niagen Bioscience shares in Q2 2026, an estimated $364K.
  • Niagen Bioscience made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1610 holding.
  • Qube Research & Technologies (QRT) first reported a position in Niagen Bioscience in Q2 2022 and has held it in 12 quarters since.
  • Qube Research & Technologies (QRT)'s Niagen Bioscience position peaked at $9.7M in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.